BRPI0411582A - substáncias terapêuticas contendo boro hidroliticamente resistentes e método de uso - Google Patents

substáncias terapêuticas contendo boro hidroliticamente resistentes e método de uso

Info

Publication number
BRPI0411582A
BRPI0411582A BRPI0411582-1A BRPI0411582A BRPI0411582A BR PI0411582 A BRPI0411582 A BR PI0411582A BR PI0411582 A BRPI0411582 A BR PI0411582A BR PI0411582 A BRPI0411582 A BR PI0411582A
Authority
BR
Brazil
Prior art keywords
therapeutic substances
containing therapeutic
hydrolytically resistant
resistant boron
compositions
Prior art date
Application number
BRPI0411582-1A
Other languages
English (en)
Inventor
Ving Lee
Jacob J Plattner
Stephen J Benkovic
Stephen J Baker
Kirk R Maples
Carolyn Bellinger-Kawahara
Tsutomu Akama
Yong-Kang Zhang
Rejeshwar Singh
Vittorio Sauro
Original Assignee
Anacor Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc filed Critical Anacor Pharmaceuticals Inc
Publication of BRPI0411582A publication Critical patent/BRPI0411582A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"SUBSTáNCIAS TERAPêUTICAS CONTENDO BORO HIDROLITICAMENTE RESISTENTES E MéTODO DE USO". São reveladas composições e métodos de uso de derivados de boro, incluindo benzoxaboros, benzazaboros e benztiaboros, como agentes terapêuticos para o tratamento de doenças causadas por bactérias ou vírus, assim como métodos para a síntese dos agentes e composições desses.
BRPI0411582-1A 2003-06-16 2004-06-15 substáncias terapêuticas contendo boro hidroliticamente resistentes e método de uso BRPI0411582A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47892103P 2003-06-16 2003-06-16
PCT/US2004/018765 WO2005013892A2 (en) 2003-06-16 2004-06-15 Hydrolytically-resistant boron-containing therapeutics and methods of use

Publications (1)

Publication Number Publication Date
BRPI0411582A true BRPI0411582A (pt) 2006-08-08

Family

ID=34135048

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411582-1A BRPI0411582A (pt) 2003-06-16 2004-06-15 substáncias terapêuticas contendo boro hidroliticamente resistentes e método de uso

Country Status (12)

Country Link
US (2) US7465836B2 (pt)
EP (1) EP1638578A4 (pt)
CN (1) CN1829521B (pt)
AU (1) AU2004262524C1 (pt)
BR (1) BRPI0411582A (pt)
CA (1) CA2529792A1 (pt)
IL (1) IL172627A0 (pt)
MX (1) MXPA05013848A (pt)
NZ (1) NZ544245A (pt)
RU (2) RU2006101228A (pt)
WO (1) WO2005013892A2 (pt)
ZA (1) ZA200600387B (pt)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0411582A (pt) * 2003-06-16 2006-08-08 Anacor Pharmaceuticals Inc substáncias terapêuticas contendo boro hidroliticamente resistentes e método de uso
US7767657B2 (en) 2005-02-16 2010-08-03 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
JP5038912B2 (ja) 2005-02-16 2012-10-03 アナコール ファーマシューティカルズ，インコーポレイテッド ホウ素含有小分子
MX335993B (es) * 2005-12-30 2016-01-07 Anacor Pharmaceuticals Inc Moleculas pequeñas que contienen boro.
NZ570257A (en) 2006-02-16 2011-11-25 Anacor Pharmaceuticals Inc Boron-containing small molecules as anti-inflammatory agents
CA2651212A1 (en) * 2006-05-02 2007-11-15 Anacor Pharmaceuticals, Inc. Hydrolytically-resistant boron-containing therapeutics and methods of use
EP1900378A1 (en) * 2006-08-31 2008-03-19 Novartis AG Pharmaceutical compositions for the treatment of fungal infections
JO3598B1 (ar) 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
JO3396B1 (ar) * 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc جزيئات صغيرة تحتوي على البورون
AU2008312355B2 (en) * 2007-10-19 2013-07-04 Janssen Pharmaceutica, N.V. Carbon linked modulators of y-secretase
BRPI0908565A2 (pt) 2008-03-06 2017-05-23 Anacor Pharmaceuticals Inc composto, formulação farmacêutica, métodos para reduzir a liberação de uma citocina ou de uma quimiocina, para tratar uma condição em um animal e para inibir uma fosfodiesterase
AU2009233711B2 (en) 2008-04-09 2015-02-12 Infinity Pharmaceuticals, Inc Inhibitors of fatty acid amide hydrolase
US8853185B2 (en) 2008-04-09 2014-10-07 Cornell University Coferons and methods of making and using them
US20100256092A1 (en) * 2008-05-12 2010-10-07 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US8461336B2 (en) 2008-09-04 2013-06-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
EP2348863A4 (en) 2008-09-04 2012-03-07 Anacor Pharmaceuticals Inc BORN SMALL MOLECULES
US9493489B2 (en) * 2008-10-15 2016-11-15 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents
MX2011006334A (es) 2008-12-17 2011-09-22 Anacor Pharmaceuticals Inc Polimorfos de (s)-3-amino-metil-7-(3-hidroxi-propoxi)-3h-benzo-[c] [1,2]-oxaborol-1-ol.
EP2416660B1 (en) 2009-04-07 2014-07-02 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
WO2010118159A1 (en) 2009-04-07 2010-10-14 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
KR20130031233A (ko) * 2009-07-28 2013-03-28 아나코르 파마슈티칼스 인코포레이티드 삼치환된 붕소 함유 분자
AP4039A (en) 2009-08-14 2017-02-28 Daitao Chen Boron-containing small molecules as antiprotozoal agents
MX2012002031A (es) * 2009-08-19 2012-07-04 Anacor Pharmaceuticals Inc Moleculas pequeñas que contienen boro como agentes antiprotozoarios.
WO2011037731A1 (en) * 2009-09-25 2011-03-31 Anacor Pharmaceuticals, Inc. Boron containing small molecules
CA2774476A1 (en) 2009-10-07 2011-04-14 Francis Barany Coferons and methods of making and using them
WO2011049971A1 (en) 2009-10-20 2011-04-28 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
US20110212918A1 (en) * 2009-11-11 2011-09-01 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2011094450A1 (en) 2010-01-27 2011-08-04 Anacor Pharmaceuticals, Inc Boron-containing small molecules
EP2531511A1 (en) 2010-02-03 2012-12-12 Infinity Pharmaceuticals, Inc. Fatty acid amide hydrolase inhibitors
AP2012006482A0 (en) 2010-03-19 2012-10-31 Anacor Pharmacueticals Inc Boron-containing small molecules as anti-protozoalagent
SG10201507032YA (en) 2010-09-07 2015-10-29 Anacor Pharmaceuticals Inc Benzoxaborole derivatives for treating bacterial infections
US8530452B2 (en) 2011-12-22 2013-09-10 Micurx Pharmaceuticals, Inc. Tricyclic boron compounds for antimicrobial therapy
DK2950644T3 (en) 2013-01-30 2017-09-04 Agrofresh Inc USE OF BENZOXABOROLS AS VOLATIVE ANTIMICROBIAL AGENTS IN MEAT, PLANTS OR PARTS
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
WO2014182954A1 (en) * 2013-05-08 2014-11-13 Colorado Seminary, Which Owns And Operates The University Of Denver Antibiotic and anti-parasitic agents that modulate class ii fructose 1,6-bisphosphate aldolase
JP6605513B2 (ja) 2014-07-01 2019-11-13 第一三共株式会社 抗菌剤としての三環式ベンゾオキサボロール
CA2974396C (en) * 2015-02-12 2024-04-30 Agrofresh Inc. Fungicidal compounds and compositions
CA3014757C (en) * 2015-08-06 2020-01-14 The Penn State Research Foundation Benzoxaborole-containing coating resistant to cellulose-supportable fungus
NZ745681A (en) 2016-03-07 2022-05-27 Agrofresh Inc Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
US11447506B2 (en) 2016-05-09 2022-09-20 Anacor Pharmaceuticals, Inc. Crystal forms of crisaborole in free form and preparation method and use thereof
EP3609504A4 (en) 2017-03-01 2021-03-03 Anacor Pharmaceuticals, Inc. NEW OXABOROLE ANALOGUES AND USES OF THE LATEST
WO2020051701A1 (en) * 2018-09-12 2020-03-19 Institut National De La Recherche Scientifique Compounds and methods for the treatment of pathogenic neisseria
CN110183477B (zh) * 2019-07-03 2022-03-04 石家庄诚志永华显示材料有限公司 有机电致发光化合物及其应用
EP4204012A1 (en) 2020-08-31 2023-07-05 Pfizer Inc. Methods of protecting rna
CN113150022B (zh) * 2021-04-23 2022-12-06 四川大学 3-取代五元环状硼酸酯衍生物及其药物组合物和制药用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9411587D0 (en) 1994-06-09 1994-08-03 Zeneca Ltd Compound, composition and use
CA2225014A1 (en) * 1997-12-16 1999-06-16 Peter Zoricak B-n heterocyclic ligands
JPWO2003033002A1 (ja) * 2001-10-11 2005-02-03 御子柴　克彦 細胞内カルシウム濃度上昇抑制剤
BRPI0411582A (pt) * 2003-06-16 2006-08-08 Anacor Pharmaceuticals Inc substáncias terapêuticas contendo boro hidroliticamente resistentes e método de uso

Also Published As

Publication number Publication date
IL172627A0 (en) 2006-04-10
AU2004262524A1 (en) 2005-02-17
RU2009139904A (ru) 2011-05-10
AU2004262524C1 (en) 2010-08-19
AU2004262524B2 (en) 2010-03-11
EP1638578A4 (en) 2009-04-01
MXPA05013848A (es) 2006-09-04
RU2006101228A (ru) 2006-07-27
CN1829521B (zh) 2011-01-26
US20090239824A1 (en) 2009-09-24
US20050054644A1 (en) 2005-03-10
CN1829521A (zh) 2006-09-06
NZ544245A (en) 2010-04-30
EP1638578A2 (en) 2006-03-29
WO2005013892A9 (en) 2005-04-14
WO2005013892A2 (en) 2005-02-17
US7968752B2 (en) 2011-06-28
US7465836B2 (en) 2008-12-16
WO2005013892A3 (en) 2005-06-16
ZA200600387B (en) 2009-06-24
CA2529792A1 (en) 2005-02-17

Similar Documents

Publication Publication Date Title
WO2005013892A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
ATE442142T1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
BR0309875A (pt) métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto
NO20093464L (no) Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika
BRPI0409969A (pt) composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto
SE0202539D0 (sv) Compounds
BR0113838A (pt) Derivados de n-fenil-2-pirimidina-amina
WO2007131072A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
SE0104140D0 (sv) Novel Compounds
TW200508214A (en) Novel compounds
SE0200920D0 (sv) Novel compounds
BRPI0418099A (pt) compostos, composição farmacêutica, e uso de um composto
AU2002314914A1 (en) Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
BR0317358A (pt) Composto de pirrolopiridazina, processo para sua preparação, composição farmacêutica contendo o mesmo, método de prevenção ou tratamento de doenças contendo o mesmo e seu uso
BRPI0410316A (pt) composto, composição farmacêutica, uso dos compostos, e, método de tratamento de distúrbios mediados por vr1 e para o tratamento de distúrbios de dores
BR0312560A (pt) Novas espiropiperidinas ou espiropirrolidinas tricìclicas
SE0300480D0 (sv) Novel compounds
BR0309343A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
SE0201544D0 (sv) Novel compounds and thier use
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
MA31567B1 (fr) Derives de 7 -alkynyl-1.8-naphthyrid0nes, leur preparation et leur application en therapeutique
SE0302546D0 (sv) New compounds
SI1730147T1 (sl) Substituirane triazaspiro dekan onskespojine za zdravljenje obezitete
BR0311491A (pt) Composto, composição farmacêutica, uso de um composto, e, método terapêutico para tratar câncer em um mamìfero
SE0401763D0 (sv) Compounds

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.